4.7 Article

Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level

期刊

CANCER DISCOVERY
卷 12, 期 1, 页码 134-153

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/2159-8290.CD-21-0316

关键词

-

类别

资金

  1. National Natural Science Foundation of China [81961128025, 91942313]
  2. Program of Shanghai Academic Research Leader [19XD1420700]
  3. Shanghai Municipal Key Clinical Specialty
  4. Strategic Priority Research Program [XDPB0303]
  5. Frontier Science Key Research Project of Chinese Academy of Sciences [QYZDB-SSW-SMC036]
  6. Shanghai Municipal Science and Technology Major Project [2019SHZDZX02]

向作者/读者索取更多资源

This study presents a single-cell and spatial atlas of colorectal liver metastasis, revealing highly metabolically activated MRCP+ CCL18(+) M2-like macrophages at the metastatic sites. Effective neoadjuvant chemotherapy can slow down this metabolic activation, raising the possibility of targeting metabolic pathways in metastasis.
Liver metastasis, the leading cause of colorectal cancer mortality, exhibits a highly heterogeneous and suppressive immune microenvironment. Here, we sequenced 97 matched samples by using single-cell RNA sequencing and spatial transcriptomics. Strikingly, the metastatic microenvironment underwent remarkable spatial reprogramming of immunosuppressive cells such as MRCP+ CCL18(+) M2-like macrophages. We further developed scMetabolism, a computational pipeline for quantifying single-cell metabolism, and observed that those macrophages harbored enhanced metabolic activity. Interestingly, neoadjuvant chemotherapy could block this status and restore the antitumor immune balance in responsive patients, whereas the nonresponsive patients deteriorated into a more suppressive one. Our work described the immune evolution of metastasis and uncovered the black box of how tumors respond to neoadjuvant chemotherapy. SIGNIFICANCE: We present a single-cell and spatial atlas of colorectal liver metastasis and found the highly metabolically activated MRCP+ CCL18(+) M2-like macrophages in metastatic sites. Efficient neoadjuvant chemotherapy can slow down such metabolic activation, raising the possibility to target metabolism pathways in metastasis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据